News

25th February 2022 - Trust isn’t just assumed in the life sciences; it’s built, tested, and validated. That professional approach has shaped Dr. Pranesh Sujaymeendra Davangere Srinivas’s journey from raising fruit flies in a makeshift lab to leading global...

WHO along with its academy and the Republic of Korea, have announced the inception of a global bio manufacturing training hub that will be of assistance to low and mid-income countries who are inclined to develop biologicals ranging from...

Earlier in February this year, Novartis, which happens to be a Swiss drug major, sold its three rooted brands to Dr Reddy’s Laboratories in India. If this wasn’t enough, they also went on to terminate 400 employees from positions,...

Contract development and manufacturing organisation (CDMO) Micro-Sphere has invested more than €1.5 million at its plant in Switzerland to expand its offering in encapsulation for inhalation products. Boosting its existing automatic capsule filling equipment Micro-Sphere has taken delivery of and...

Recipharm, the Swedish CDMO, which happens to be Moderna’s COVID-19 vaccine production partner, has undergone not one but two acquisitions in the week ending February 19th. This expansion is a part of a strategy that Recipharm has been eyeing...

Xanadu Bio, in association with Yale University, has come up with a nanoparticle delivery platform that will help to position itself to give its expertise in the COVID-19 booster vaccines that may prove to be more efficient in stopping...

Recipharm, a global contract development and manufacturing organisation (CDMO), is continuing to build its service offerings in new biologic modalities through the acquisition of Vibalogics, a virotherapy CDMO and a portfolio company of Ampersand Capital Partners. Vibalogics holds a...